122 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
1
Discovery of an Orally Selective Inhibitor of Signal Transducer and Activator of Transcription 3 Using Advanced Multiple Ligand Simultaneous Docking.
The Ohio State University
1
4-Carbonyl-2,6-dibenzylidenecyclohexanone derivatives as small molecule inhibitors of STAT3 signaling pathway.
Soochow University
15
Neuroactive and Anti-inflammatory Frankincense Cembranes: A Structure-Activity Study.
University of Eastern Piedmont
39
Optimization of pyrazole-containing 1,2,4-triazolo-[3,4-b]thiadiazines, a new class of STAT3 pathway inhibitors.
University of Pittsburgh
1
Turmeric Sesquiterpenoids: Expeditious Resolution, Comparative Bioactivity, and a New Bicyclic Turmeronoid.
University of Eastern Piedmont
1
Synthesis of natural phaeosphaeride A derivatives and an in vitro evaluation of their anti-cancer potential.
Research Institute of Hygiene
1
Novel aminotetrazole derivatives as selective STAT3 non-peptide inhibitors.
University of Franche-Comt£
8
Hirsutinolide Series Inhibit Stat3 Activity, Alter GCN1, MAP1B, Hsp105, G6PD, Vimentin, TrxR1, and Importina-2 Expression, and Induce Antitumor Effects against Human Glioma.
University of Hawaii At Hilo
5
N-Sulfonyl-aminobiaryls as Antitubulin Agents and Inhibitors of Signal Transducers and Activators of Transcription 3 (STAT3) Signaling.
Taipei Medical University
32
2-Guanidinoquinazolines as new inhibitors of the STAT3 pathway.
University of Pittsburgh
11
Isolation and Characterization of Dammarane-Type Saponins from Gynostemma pentaphyllum and Their Inhibitory Effects on IL-6-Induced STAT3 Activation.
Chungbuk National University
25
Nanomolar-Potency Small Molecule Inhibitor of STAT5 Protein.
University of Toronto Mississauga
16
SAR studies on curcumin's pro-inflammatory targets: discovery of prenylated pyrazolocurcuminoids as potent and selective novel inhibitors of 5-lipoxygenase.
University Jena
1
A perylene derivative regulates HIF-1a and Stat3 signaling pathways.
Baylor College of Medicine
3
Potent Targeting of the STAT3 Protein in Brain Cancer Stem Cells: A Promising Route for Treating Glioblastoma.
University of Toronto At Mississauga
80
Inhibiting aberrant signal transducer and activator of transcription protein activation with tetrapodal, small molecule Src homology 2 domain binders: promising agents against multiple myeloma.
University of Toronto Mississauga
3
Anticancer activity and SAR studies of substituted 1,4-naphthoquinones.
The Ohio State University
1
Discovery of novel STAT3 small molecule inhibitors via in silico site-directed fragment-based drug design.
The Ohio State University
4
Identification and characterization of small molecule inhibitors of signal transducer and activator of transcription 3 (STAT3) signaling pathway by virtual screening.
Fudan University
3
Discovery of novel inhibitors of signal transducer and activator of transcription 3 (STAT3) signaling pathway by virtual screening.
Fudan University
23
Small molecule inhibitors of signal transducer and activator of transcription 3 (Stat3) protein.
University of Southern California
10
Small molecule STAT5-SH2 domain inhibitors exhibit potent antileukemia activity.
University of Toronto
46
Identification of Purine-Scaffold Small-Molecule Inhibitors of Stat3 Activation by QSAR Studies.
TBA
17
Discovery of 5-chloro-N2-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine (AZD1480) as a novel inhibitor of the Jak/Stat pathway.
AstraZeneca
1
Cucurbitane-type triterpenoids from the stems of Cucumis melo.
Chinese Academy of Sciences
16
Identification of a non-phosphorylated, cell permeable, small molecule ligand for the Stat3 SH2 domain.
University of Toronto Mississauga
17
Potent and selective phosphopeptide mimetic prodrugs targeted to the Src homology 2 (SH2) domain of signal transducer and activator of transcription 3.
University of Texas M. D. Anderson Cancer Center
1
Identification of Niclosamide as a New Small-Molecule Inhibitor of the STAT3 Signaling Pathway.
TBA
15
Design, synthesis, and in vitro characterization of novel hybrid peptidomimetic inhibitors of STAT3 protein.
University of Toronto
50
Structure-affinity relationships of glutamine mimics incorporated into phosphopeptides targeted to the SH2 domain of signal transducer and activator of transcription 3.
The University of Texas M.D. Anderson Cancer Center
35
Conformationally constrained peptidomimetic inhibitors of signal transducer and activator of transcription. 3: Evaluation and molecular modeling.
The University of Texas M.D. Anderson Cancer Center
47
Discovery of 4-(benzylaminomethylene)isoquinoline-1,3-(2H,4H)-diones and 4-[(pyridylmethyl)aminomethylene]isoquinoline-1,3-(2H,4H)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4.
Wyeth Research
2
Discovery of the catechol structural moiety as a Stat3 SH2 domain inhibitor by virtual screening.
Wyeth Pharmaceuticals
5
Inhibition of the signal transducer and activator of transcription-3 (STAT3) signaling pathway by 4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxylic acid esters.
Wyeth Research
2
STATs, promising targets for the treatment of autoimmune and inflammatory diseases.
Sichuan University
1
Structural optimization and characterization of highly potent and selective STAT3 inhibitors for the treatment of triple negative breast cancer.
Kunming Medical University
5
Novel Cyclic Peptides as Interleukin-23 Inhibitor for Treating Inflammatory Disorders.
Emory University
1
Discovery of naphthoquinone-furo-piperidone derivatives as dual targeting agents of STAT3 and NQO1 for the treatment of breast cancer.
Zhejiang University
3
Discovery of SD-436: A Potent, Highly Selective and Efficacious STAT3 PROTAC Degrader Capable of Achieving Complete and Long-Lasting Tumor Regression.
University of Michigan
7
Biological evaluation of signal transducer and activator of transcription 3 (STAT3) targeting by phaeosphaeride A and its analogs.
Health Sciences University of Hokkaido
74
Small molecule inhibitor screen identifies synergistic activity of the bromodomain inhibitor CPI203 and bortezomib in drug resistant myeloma.
Knight Cancer Institute
5
CYT387, a selective JAK1/JAK2 inhibitor: in vitro assessment of kinase selectivity and preclinical studies using cell lines and primary cells from polycythemia vera patients.
Mayo Clinic
2
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia.
University of Cambridge
3
NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family.
Johann Wolfgang Goethe University
2
Natural Product-Inspired Discovery of Naphthoquinone-Furo-Piperidine Derivatives as Novel STAT3 Inhibitors for the Treatment of Triple-Negative Breast Cancer.
Zhejiang University
1
Design, Synthesis, and Biological Activity of Novel Quinone Derivatives as Potent STAT3 Inhibitors for Psoriasis Treatment.
Central South University
11
Azetidine ring, salicylic acid, and salicylic acid bioisosteres as determinants of the binding characteristics of novel potent compounds to Stat3.
Cedars-Sinai Medical Center
1
Drug Repurposing of ACT001 to Discover Novel Promising Sulfide Prodrugs with Improved Safety and Potent Activity for Neutrophil-Mediated Antifungal Immunotherapy.
Tongji University
22
Emerging opportunities to treat idiopathic pulmonary fibrosis: Design, discovery, and optimizations of small-molecule drugs targeting fibrogenic pathways.
Institute of Respiratory Health
6
Targeted regulated cell death with small molecule compounds in colorectal cancer: Current perspectives of targeted therapy and molecular mechanisms.
Sichuan University
61
Exploration of novel isoxazole-fused quinone derivatives as anti-colorectal cancer agents through inhibiting STAT3 and elevating ROS level.
Sichuan University
47
Development and Therapeutic Implications of Tyrosine Kinase 2 Inhibitors.
China Pharmaceutical University
8
Design, Synthesis, and Biological Activity of Marinacarboline Analogues as STAT3 Pathway Inhibitors for Docetaxel-Resistant Triple-Negative Breast Cancer.
Seoul National University
37
Identification and Biological Evaluation of a Potent and Selective JAK1 Inhibitor for the Treatment of Pulmonary Fibrosis.
Ewha Womans University
6
New syntheses of tetrazolylmethylphenylalanine and O-malonyltyrosine as pTyr mimetics for the design of STAT3 dimerization inhibitors.
Université
21
Dual-target Janus kinase (JAK) inhibitors: Comprehensive review on the JAK-based strategies for treating solid or hematological malignancies and immune-related diseases.
China Pharmaceutical University
1
Perspective for Discovery of Small Molecule IL-6 Inhibitors through Study of Structure-Activity Relationships and Molecular Docking.
Dongguk University
30
Eyes on Topical Ocular Disposition: The Considered Design of a Lead Janus Kinase (JAK) Inhibitor That Utilizes a Unique Azetidin-3-Amino Bridging Scaffold to Attenuate Off-Target Kinase Activity, While Driving Potency and Aqueous Solubility.
Alcon Research
1
Research progress of STAT3-based dual inhibitors for cancer therapy.
Xinxiang University
1
Discovery, Optimization, and Evaluation of Novel
Chinese Academy of Medical Sciences & Peking Union Medical College
3
Solid-phase synthesis of Stat3 inhibitors incorporating O-carbamoylserine and O-carbamoylthreonine as glutamine mimics.
The University of Texas
1
PROTACs: New method to degrade transcription regulating proteins.
Shenyang Pharmaceutical University
20
Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders.
China Pharmaceutical University
10
Anti-inflammatory activity of naturally occuring diarylheptanoids - A review.
Universita Paul Sabatier
4
Allosteric inhibitors of the STAT3 signaling pathway.
West China Second University Hospital
21
Revisiting signal transducer and activator of transcription 3 (STAT3) as an anticancer target and its inhibitor discovery: Where are we and where should we go?
Sun Yat-Sen University
15
Recent Update on Development of Small-Molecule STAT3 Inhibitors for Cancer Therapy: From Phosphorylation Inhibition to Protein Degradation.
Cancer Hospital of The University of Chinese Academy of Sciences (Zhejiang Cancer Hospital)
2
Boronic Acid: A Novel Pharmacophore Targeting Src Homology 2 (SH2) Domain of STAT3.
Sun Yat-Sen University
8
Discovery of 2-Amino-3-cyanothiophene Derivatives as Potent STAT3 Inhibitors for the Treatment of Osteosarcoma Growth and Metastasis.
East China Normal University
1
Discovery of STAT3 and Histone Deacetylase (HDAC) Dual-Pathway Inhibitors for the Treatment of Solid Cancer.
China Pharmaceutical University
1
Telocinobufagin Has Antitumor Effects in Non-Small-Cell Lung Cancer by Inhibiting STAT3 Signaling.
Wenzhou Medical University
55
Discovery of a Novel Potent STAT3 Inhibitor HP590 with Dual p-Tyr
East China Normal University
4
S3I-201 derivative incorporating naphthoquinone unit as effective STAT3 inhibitors: Design, synthesis and anti-gastric cancer evaluation.
Zhejiang Chinese Medical University
41
Discovery of a Highly Potent and Orally Bioavailable STAT3 Dual Phosphorylation Inhibitor for Pancreatic Cancer Treatment.
East China Normal University
4
Recent advances of quinones as a privileged structure in drug discovery.
Jinan Second People'S Hospital
1
Structure-based discovery of potent and selective small-molecule inhibitors targeting signal transducer and activator of transcription 3 (STAT3).
Sun Yat-Sen University
37
Rational drug design of benzothiazole-based derivatives as potent signal transducer and activator of transcription 3 (STAT3) signaling pathway inhibitors.
Fudan University
4
Discovery of N-substituted sulfamoylbenzamide derivatives as novel inhibitors of STAT3 signaling pathway based on Niclosamide.
The First Affiliated Hospital of Wenzhou Medical University
6
Recent Advances in the Development of PD-L1 Modulators: Degraders, Downregulators, and Covalent Inhibitors.
Southern Medical University
2
Design, synthesis and biological evaluation of novel potent STAT3 inhibitors based on BBI608 for cancer therapy.
Shanghai University of Traditional Chinese Medicine
3
NO-releasing STAT3 inhibitors suppress BRAF-mutant melanoma growth.
The University of Texas At Austin
1
Screening and biological evaluation of a novel STAT3 signaling pathway inhibitor against cancer.
Dalian Medical University
2
SD-91 as A Potent and Selective STAT3 Degrader Capable of Achieving Complete and Long-Lasting Tumor Regression.
University of Michigan
11
Structure-Activity Study of Nitazoxanide Derivatives as Novel STAT3 Pathway Inhibitors.
Peking University Health Science Center
15
Discovery of a Napabucasin PROTAC as an Effective Degrader of the E3 Ligase ZFP91.
University of Michigan
76
Discovery of Novel Azetidine Amides as Potent Small-Molecule STAT3 Inhibitors.
University of Hawaii Cancer Center
2
A panoramic review of IL-6: Structure, pathophysiological roles and inhibitors.
Punjabi University
4
STAT3 inhibitory activity of naphthoquinones isolated from Tabebuia avellanedae.
Kindai University
22
Isoalantolactone/hydroxamic acid hybrids as potent dual STAT3/HDAC inhibitors and self-assembled nanoparticles for cancer therapy.
Wuyi University
8
Allosteric Modulator Discovery: From Serendipity to Structure-Based Design.
Shanghai Jiao-Tong University School of Medicine
7
Design, synthesis and activity of novel 2,6-disubstituted purine derivatives, potential small molecule inhibitors of signal transducer and activator of transcription 3.
Wenzhou Medical University
1
A novel series of napabucasin derivatives as orally active inhibitors of signal transducer and activator of transcription 3 (STAT3).
Sichuan University
58
Bifunctional Naphthoquinone Aromatic Amide-Oxime Derivatives Exert Combined Immunotherapeutic and Antitumor Effects through Simultaneous Targeting of Indoleamine-2,3-dioxygenase and Signal Transducer and Activator of Transcription 3.
Guangxi Normal University
11
Structure-Based Discovery of SD-36 as a Potent, Selective, and Efficacious PROTAC Degrader of STAT3 Protein.
TBA
1
Towards lead compounds as anti-cancer agents via new phaeosphaeride A derivatives.
Federal Medical Biological Agency
7
Small-molecule compounds targeting the STAT3 DNA-binding domain suppress survival of cisplatin-resistant human ovarian cancer cells by inducing apoptosis.
Peking Union Medical College
37
Linker Variation and Structure-Activity Relationship Analyses of Carboxylic Acid-based Small Molecule STAT3 Inhibitors.
University of Hawaii Cancer Center
2
Piperlongumine derivative, CG-06, inhibits STAT3 activity by direct binding to STAT3 and regulating the reactive oxygen species in DU145 prostate carcinoma cells.
Chungnam National University
18
Electrophilic Triterpenoid Enones: A Comparative Thiol-Trapping and Bioactivity Study.
University of Eastern Piedmont
33
Andrographolide derivative as STAT3 inhibitor that protects acute liver damage in mice.
University of Macau
2
Napabucasin and Related Heterocycle-Fused Naphthoquinones as STAT3 Inhibitors with Antiproliferative Activity against Cancer Cells.
Westphalian Wilhelms University
26
Cornusides A-O, Bioactive Iridoid Glucoside Dimers from the Fruit of Cornus officinalis.
Beijing University of Chinese Medicine
3
A small-molecule screen identifies the antitrypanosomal agent suramin and analogues NF023 and NF449 as inhibitors of STAT5a/b.
Leipzig University
188
Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinases
Array Biopharma
83
Substituted benzothienyl-pyrrolotriazines and uses thereof in the treatment cancer
Bayer Intellectual Property
64
Substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-C]pyridines, their use as medicament, and pharmaceutical preparations comprising them
Sanofi
8
Proteome-wide Profiling of Clinical PARP Inhibitors Reveals Compound-Specific Secondary Targets.
H. Lee Moffitt Cancer Center & Research Institute
5
Active site ring-opening of a thiirane moiety and picomolar inhibition of gelatinases.
University of Notre Dame